Investors Research Corp’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,290
Closed -$11.1K 1132
2023
Q1
$11.1K Hold
9,290
﹤0.01% 757
2022
Q4
$13.2K Hold
9,290
﹤0.01% 727
2022
Q3
$23K Hold
9,290
0.01% 631
2022
Q2
$21K Hold
9,290
0.01% 657
2022
Q1
$63K Buy
9,290
+40
+0.4% +$342 0.02% 485
2021
Q4
$84K Sell
9,250
-40
-0.4% -$372 0.03% 441
2021
Q3
$94K Hold
9,290
0.03% 411
2021
Q2
$119K Hold
9,290
0.04% 364
2021
Q1
$131K Buy
9,290
+400
+4% +$5.51K 0.05% 347
2020
Q4
$95K Sell
8,890
-650
-7% -$5.9K 0.04% 424
2020
Q3
$73K Hold
9,540
0.04% 434
2020
Q2
$58K Hold
9,540
0.03% 457
2020
Q1
$34K Hold
9,540
0.02% 511
2019
Q4
$101K Hold
9,540
0.05% 409
2019
Q3
$107K Hold
9,540
0.05% 393
2019
Q2
$87K Hold
9,540
0.05% 406
2019
Q1
$106K Buy
+9,540
New +$66.7K 0.06% 374

Other funds holding DBD

Investors Research Corp's DBD Position: Q2 2023 in Review

Investors Research Corp sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 9,290 shares — an estimated $11.1K sold.

Investors Research Corp first reported a position in DBD in Q1 2019 and held it in 17 quarters. The position peaked at $131K in Q1 2021. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.

  • Investors Research Corp reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
  • Investors Research Corp sold 9,290 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $11.1K.
  • Investors Research Corp first reported a position in Diebold Nixdorf Incorporated in Q1 2019 and held it in 17 quarters.
  • Investors Research Corp's Diebold Nixdorf Incorporated position peaked at $131K in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.

Based on Investors Research Corp's 13F filing for Q2 2023, filed 14 Aug 2023.